Log in

Relevant bibliographies by topics / Early tumor detection / Journal articles

To see the other types of publications on this topic, follow the link: Early tumor detection.

Journal articles on the topic 'Early tumor detection'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Early tumor detection.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sultana, Zakia, Md Ashikur Rahman Khan, and Nusrat Jahan. "Early Breast Cancer Detection Utilizing Artificial Neural Network." WSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE 18 (March 18, 2021): 32–42. http://dx.doi.org/10.37394/23208.2021.18.4.

Full text

Abstract:

Breast cancer is one of the most dangerous cancer diseases for women in worldwide. A Computeraided diagnosis system is very helpful for radiologist for diagnosing micro calcification patterns earlier and faster than typical screening techniques. Maximum breast cancer cells are eventually form a lump or mass called a tumor. Moreover, some tumors are cancerous and some are not cancerous. The cancerous tumors are called malignant and non-cancerous tumors are called benign. The benign tumors are not dangerous to health. But the unchecked malignant tumors have the ability to spread in other organs

APA, Harvard, Vancouver, ISO, and other styles

2

Song, Jin-Qi, Ya-Nan Zhou, Gang-Liang Tu, Chang-Li Xu, and Hui Xu. "Detection of Circulating Tumor Cells and Its Application in Prostate Cancer." Nepalese Journal of Cancer 4, no. 1 (2020): 3–7. http://dx.doi.org/10.3126/njc.v4i1.31685.

Full text

Abstract:

In recent years, circulating tumor cells have become the focus of tumor research. In-depth study of the role of circulating tumor cells in the genesis, development, and evolution of tumors will be of great significance for the early detection, early diagnosis, early treatment, and prognosis of tumors. Prostate cancer is one of the common male malignant tumors, and the role of circulating tumor cells in prostate cancer has been increasing year by year. This article will focus on the progress of circulating tumor cells detection and its application in prostate cancer.

APA, Harvard, Vancouver, ISO, and other styles

3

Tazeen, Tasmiya, and Mrinal Sarvagya. "Brain Tumor Segmentation and Classification using Multiple Feature Extraction and Convolutional Neural Networks." International Journal of Engineering and Advanced Technology 10, no. 6 (2021): 23–27. http://dx.doi.org/10.35940/ijeat.f2948.0810621.

Full text

Abstract:

Intracranial tumors are a type of cancer that grows spontaneously inside the skull. Brain tumor is the cause for one in four deaths. Hence early detection of the tumor is important. For this aim, a variety of segmentation techniques are available. The fundamental disadvantage of present approaches is their low segmentation accuracy. With the help of magnetic resonance imaging (MRI), a preventive medical step of early detection and evaluation of brain tumor is done. Magnetic resonance imaging (MRI) offers detailed information on human delicate tissue, which aids in the diagnosis of a brain tumo

APA, Harvard, Vancouver, ISO, and other styles

4

Massari, Francesco, Vincenzo Di Nunno, Francesca Comito, et al. "Circulating tumor cells in genitourinary tumors." Therapeutic Advances in Urology 10, no. 2 (2017): 65–77. http://dx.doi.org/10.1177/1756287217742564.

Full text

Abstract:

Management of advanced urogenital malignancies has profoundly changed in recent years due to the development of novel targeted drugs that have significantly improved patient’s clinical outcomes. This process has been made possible mainly thanks to better knowledge of tumor genetic alterations and molecular altered pathways. Despite these remarkable results, several issues such as early detection of the disease as well as the research into early markers of recurrence or disease progression still remain an open challenge for clinical research. The detection of circulating tumor cells and circula

APA, Harvard, Vancouver, ISO, and other styles

5

Recht, Lawrence D., Griffith Harsh IV, and Harvey J. Cohen. "The rationale for early detection and treatment of brain tumors in survivors of childhood cancer." Oncology Reviews 3, no. 1 (2011): 51. http://dx.doi.org/10.4081/oncol.2009.51.

Full text

Abstract:

Survivors of childhood cancer have a relatively high risk of developing second cancers. The incidence of brain tumor in these patients approaches 1% at 10 years, over 80-fold that in the general population. This high incidence increases the likelihood that early detection of brain tumors in survivors of childhood cancer is feasible. By analogy with other epithelial cancers, detection and treatment of brain tumors at a pre-neoplastic or premalignant stage may render screening and treatment cost effective for certain high-risk populations. Our animal studies with a clinically appropriate model o

APA, Harvard, Vancouver, ISO, and other styles

6

Fiala, Clare, Vathany Kulasingam, and Eleftherios P. Diamandis. "Circulating Tumor DNA for Early Cancer Detection." Journal of Applied Laboratory Medicine 3, no. 2 (2018): 300–313. http://dx.doi.org/10.1373/jalm.2018.026393.

Full text

Abstract:

AbstractBackgroundCancer cells release circulating tumor DNA (ctDNA) into the bloodstream, which can now be quantified and examined using novel high-throughput sequencing technologies. This has led to the emergence of the “liquid biopsy,” which proposes to analyze this genetic material and extract information on a patient's cancer using a simple blood draw.ContentctDNA has been detected in many advanced cancers. It has also been proven to be a highly sensitive indicator of relapse and prognosis. Sequencing the genetic material has also led to the discovery of mutations targetable by existing t

APA, Harvard, Vancouver, ISO, and other styles

7

Ariztia, Edgardo V., Catherine J. Lee, Radhika Gogoi, and David A. Fishman. "The Tumor Microenvironment: Key to Early Detection." Critical Reviews in Clinical Laboratory Sciences 43, no. 5-6 (2006): 393–425. http://dx.doi.org/10.1080/10408360600778836.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Khadzhimba, Anzhella S. "Current feasibilities of early ovarian cancer detection." Journal of obstetrics and women's diseases 65, no. 1 (2016): 69–74. http://dx.doi.org/10.17816/jowd65169-74.

Full text

Abstract:

We analyzed results of laparoscopic surgical treatment of 349 patients with ovarian tumors. Before surgery besides standard examination ultrasonography of pelvis and Ca-125 estimation was performed. After comparing of preoperative diagnosis with histopatological report was identified low sensitivity and specificity of ultrasonography and Ca-125 for assessment of tumor malignancy potential (32,35 %, 31,82 % and 72,55 %, 68,36 % respectively). It was concluded that nowadays the only method of early ovarian cancer detection is surgical treatment of patients with ovarian tumors, who have ultrasono

APA, Harvard, Vancouver, ISO, and other styles

9

Klement, Giannoula, Lena Kikuchi, Mark Kieran, Nava Almog, Tai-Tung Yip, and Judah Folkman. "Early Tumor Detection Using Platelet Uptake of Angiogenesis Regulators." Blood 104, no. 11 (2004): 839. http://dx.doi.org/10.1182/blood.v104.11.839.839.

Full text

Abstract:

Abstract We report a new function for platelets: selective sequestration of tumor-derived angiogenesis regulatory proteins above the concentration of these molecules in plasma. Iodinated VEGF in a Matrigel pellet (from 100 to 600 ng/100 microl), implanted subcutaneously in mice, accumulates almost exclusively in platelets in a dose-dependent manner over a period as long as 2–3 weeks, without raising plasma levels of VEGF. Similarly, platelet VEGF increases in the presence of a single microscopic VEGF-secreting human tumor of up to only 1 mm3 in SCID mice without any increase of VEGF in plasma.

APA, Harvard, Vancouver, ISO, and other styles

10

Joo, Ijin, and Jeong Min Lee. "Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection." Abdominal Imaging 38, no. 6 (2013): 1334–50. http://dx.doi.org/10.1007/s00261-013-0027-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Diamandis, Eleftherios P., and Clare Fiala. "Can circulating tumor DNA be used for direct and early stage cancer detection?" F1000Research 6 (December 13, 2017): 2129. http://dx.doi.org/10.12688/f1000research.13440.1.

Full text

Abstract:

In the August 16th issue of Science Translational Medicine, Phallen et al propose a method for early cancer diagnosis by using circulating tumor DNA (1). One major advance of this paper includes optimized sequencing of cell-free/circulating tumor DNA (ctDNA) without knowledge of tumor mutations. Evaluation of 200 patients with colorectal, breast, lung and ovarian cancer revealed mutations in ctDNA in approx. 60-70% of all patients, including stage 1 and stage 2 disease. If this data can be reproduced in asymptomatic individuals, they will likely have a major impact on early cancer detection an

APA, Harvard, Vancouver, ISO, and other styles

12

Dréau, Didier, Laura Jeffords Moore, Lopamudra Das Roy, Shu-ta Wu, Rahul Puri, and Pinku Mukherjee. "Early detection of mammary tumors in vivo using a highly specific tumor antibody." Journal of Clinical Oncology 33, no. 28_suppl (2015): 14. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.14.

Full text

Abstract:

14 Background: Earlier detection of abnormal cells using target-specific techniques holds great promise. One of those targets Mucin-1 (MUC1) is expressed as a hypo-glycosylated form (i.e., tMUC1) in 95% of breast tumors and plays a crucial role in cancer progression. We have developed Tab004, a monoclonal antibody highly specific to a protein sequence accessible in tMUC1. Here we present data assessing the specificity and sensitivity of Tab004 in vitro and in genetically engineered mice in vivo overtime. Methods: We have developed human MUC1 Tg mice that were bred to mice that carry the oncoge

APA, Harvard, Vancouver, ISO, and other styles

13

HIRAHARA, Hiroshi, and Kohji KOSHIJI. "Microwave imaging for early-stage breast tumor detection." Journal of Life Support Engineering 20, Supplement (2008): 183. http://dx.doi.org/10.5136/lifesupport.20.supplement_183.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

N.Shah, Naishil, Tushar V. Ratanpara, and C. K. Bhensdadia. "Early Breast Cancer Tumor Detection on Mammogram Images." International Journal of Computer Applications 87, no. 14 (2014): 14–18. http://dx.doi.org/10.5120/15275-3871.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Ren, Juan, Hui Cai, Yi Li, et al. "Tumor markers for early detection of ovarian cancer." Expert Review of Molecular Diagnostics 10, no. 6 (2010): 787–98. http://dx.doi.org/10.1586/erm.10.39.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Corcoran, Ryan B. "Circulating Tumor DNA: Clinical Monitoring and Early Detection." Annual Review of Cancer Biology 3, no. 1 (2019): 187–201. http://dx.doi.org/10.1146/annurev-cancerbio-030518-055719.

Full text

Abstract:

Roughly 70 years after the presence of cell-free DNA (cfDNA) in circulating blood was discovered, cfDNA has emerged as a transformative technology in clinical oncology. The ability to assess the presence, level, and composition of tumor DNA from a routine, noninvasive blood draw has opened the door to a broad array of high-impact clinical applications. While cfDNA is rapidly gaining clinical favor as a means of tumor mutational profiling without the need for an invasive biopsy, emerging applications in the areas of clinical monitoring and early cancer detection hold tremendous promise. These d

APA, Harvard, Vancouver, ISO, and other styles

17

Avanzini, Stefano, David M. Kurtz, Jacob J. Chabon, et al. "A mathematical model of ctDNA shedding predicts tumor detection size." Science Advances 6, no. 50 (2020): eabc4308. http://dx.doi.org/10.1126/sciadv.abc4308.

Full text

Abstract:

Early cancer detection aims to find tumors before they progress to an incurable stage. To determine the potential of circulating tumor DNA (ctDNA) for cancer detection, we developed a mathematical model of tumor evolution and ctDNA shedding to predict the size at which tumors become detectable. From 176 patients with stage I to III lung cancer, we inferred that, on average, 0.014% of a tumor cell’s DNA is shed into the bloodstream per cell death. For annual screening, the model predicts median detection sizes of 2.0 to 2.3 cm representing a ~40% decrease from the current median detection size

APA, Harvard, Vancouver, ISO, and other styles

18

Pelkey, T. J., H. F. Frierson, and D. E. Bruns. "Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors." Clinical Chemistry 42, no. 9 (1996): 1369–81. http://dx.doi.org/10.1093/clinchem/42.9.1369.

Full text

Abstract:

Abstract Histological, immunological, and molecular methods have been used for detecting micrometastases from nonhematopoietic malignancies. Early studies utilizing cytological methods to identify circulating tumor cells demonstrated the uncertain significance of micrometastasis detection for predicting eventual recurrent disease. Recently, reverse transcriptase-polymerase chain reaction (RT-PCR) for the detection of circulating tumor cells has been suggested as a potential technique for staging of cancer. Studies using RT-PCR thus far indicate that test results may be negative in some patient

APA, Harvard, Vancouver, ISO, and other styles

19

King, Daniel, Ash A. Alizadeh, and George A. Fisher. "Detection of circulating tumor DNA in pancreas cancer." Journal of Clinical Oncology 38, no. 4_suppl (2020): 645. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.645.

Full text

Abstract:

645 Background: Pancreas cancer remains a leading cause of cancer-related death. Improved detection of early relapse or early failure of chemotherapy also has the potential to further improve outcomes. Exploring circulating tumor DNA (ctDNA) in this setting is an area of active investigation. Methods: We previously developed an approach, CAPP-Seq, combining high-depth sequencing with several strategies of error-suppression to identify minute amounts of circulating tumor DNA. We then trained and validated a new capture panel for pancreas cancer from 640 tumors from three data sources (TCGA, ICG

APA, Harvard, Vancouver, ISO, and other styles

20

Bredno, Joerg, Jafi Lipson, Oliver Venn, Alexander M. Aravanis, and Arash Jamshidi. "Clinical correlates of circulating cell-free DNA tumor fraction." PLOS ONE 16, no. 8 (2021): e0256436. http://dx.doi.org/10.1371/journal.pone.0256436.

Full text

Abstract:

Background Oncology applications of cell-free DNA analysis are often limited by the amount of circulating tumor DNA and the fraction of cell-free DNA derived from tumor cells in a blood sample. This circulating tumor fraction varies widely between individuals and cancer types. Clinical factors that influence tumor fraction have not been completely elucidated. Methods and findings Circulating tumor fraction was determined for breast, lung, and colorectal cancer participant samples in the first substudy of the Circulating Cell-free Genome Atlas study (CCGA; NCT02889978; multi-cancer early detect

APA, Harvard, Vancouver, ISO, and other styles

21

Yang, Shi Ping, Xiao Xia, and Xu Li. "Study on the Influence Factors of Spectrum for the early Breast Tumor Detection." Advanced Materials Research 647 (January 2013): 310–14. http://dx.doi.org/10.4028/www.scientific.net/amr.647.310.

Full text

Abstract:

Ultra-Wideband (UWB) microwave imaging is investigated as a promising method for the early-stage breast cancer detection based on the large contrast of electric parameters between the tumor and the normal breast tissue. The planer two-dimensional breast model is used to simulate the microwave propagation by the finite difference time domain (FDTD) method in the breast. In this paper, the relationship between the frequency spectrum and the permittivity is studied. The spectrum peaks of tumor change obviously with the increase of the tumor relative permittivity. Meanwhile, the size of tumor has

APA, Harvard, Vancouver, ISO, and other styles

22

Schiffman, Joshua D., Paul G. Fisher, and Peter Gibbs. "Early Detection of Cancer: Past, Present, and Future." American Society of Clinical Oncology Educational Book, no. 35 (May 2015): 57–65. http://dx.doi.org/10.14694/edbook_am.2015.35.57.

Full text

Abstract:

Screening in both healthy and high-risk populations offers the opportunity to detect cancer early and with an increased opportunity for treatment and curative intent. Currently, a defined role for screening exists in some cancer types, but each screening test has limitations, and improved screening methods are urgently needed. Unfortunately, many cancers still lack effective screening recommendations, or in some cases, the benefits from screening are marginal when weighed against the potential for harm. Here we review the current status of cancer screening: we examine the role of traditional t

APA, Harvard, Vancouver, ISO, and other styles

23

Han, Ken-ryu. "Tumor markers for the early detection of bladder cancer." Frontiers in Bioscience 7, no. 1-3 (2002): e19. http://dx.doi.org/10.2741/han.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Campos-Carrillo, Andrea, Jeffrey N. Weitzel, Prativa Sahoo, et al. "Circulating tumor DNA as an early cancer detection tool." Pharmacology & Therapeutics 207 (March 2020): 107458. http://dx.doi.org/10.1016/j.pharmthera.2019.107458.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Meany, Danni L., Lori J. Sokoll, and Daniel W. Chan. "Early detection of cancer: immunoassays for plasma tumor markers." Expert Opinion on Medical Diagnostics 3, no. 6 (2009): 597–605. http://dx.doi.org/10.1517/17530050903266830.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Han, Ken-ryu. "Tumor markers for the early detection of bladder cancer." Frontiers in Bioscience 7, no. 5 (2002): e19-26. http://dx.doi.org/10.2741/a901.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Routman, David M., Bhishamjit S. Chera, and Gaorav P. Gupta. "Circulating Tumor DNA Biomarkers for Early Detection of Oligometastasis." Cancer Journal 26, no. 2 (2020): 116–23. http://dx.doi.org/10.1097/ppo.0000000000000437.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Brychta, Nora, Thomas Krahn, and Oliver von Ahsen. "Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer." Clinical Chemistry 62, no. 11 (2016): 1482–91. http://dx.doi.org/10.1373/clinchem.2016.257469.

Full text

Abstract:

Abstract BACKGROUND Since surgical removal remains the only cure for pancreatic cancer, early detection is of utmost importance. Circulating biomarkers have potential as diagnostic tool for pancreatic cancer, which typically causes clinical symptoms only in advanced stage. Because of their high prevalence in pancreatic cancer, KRAS proto-oncogene, GTPase [KRAS (previous name: Kirsten rat sarcoma viral oncogene homolog)] mutations may be used to identify tumor-derived circulating plasma DNA. Here we tested the diagnostic sensitivity of chip based digital PCR for the detection of KRAS mutations

APA, Harvard, Vancouver, ISO, and other styles

29

Ueda, Shigeto, and Toshiaki Saeki. "Early Therapeutic Prediction Based on Tumor Hemodynamic Response Imaging: Clinical Studies in Breast Cancer with Time-Resolved Diffuse Optical Spectroscopy." Applied Sciences 9, no. 1 (2018): 3. http://dx.doi.org/10.3390/app9010003.

Full text

Abstract:

This study reports data from three clinical studies using the time-resolved diffuse optical spectroscopy (TRS) system among breast cancer patients. The parameters of oxy-hemoglobin (O2Hb), deoxy-hemoglobin (HHb), total hemoglobin (tHb), and oxygen saturation (SO2) were evaluated using TRS, and its efficacy was tested in three trials. In trial 1, we recruited 118 patients with primary breast cancer to estimate the tumor detection rate. The cumulative detection rate was 62.7%, while that in T stage 0 was 31.3% and in T stage 1 was 44.7%. These were lower than those of T stage 2 (78.9%) and T sta

APA, Harvard, Vancouver, ISO, and other styles

30

B C, Anil, and Dr Dayananda P. "Study on Segmentation and Liver Tumor Detection Methods." International Journal of Engineering & Technology 7, no. 3.4 (2018): 28. http://dx.doi.org/10.14419/ijet.v7i3.4.14670.

Full text

Abstract:

Cancer plays a major risk for public health worldwide. According to the survey made by the cancer society predicts approximate about 42,220 new cases will be diagnosed and around 32,220 people will die of this cancer that is around 71% of people will die in 2018 and Liver cancer rate is increased by 3% for every year since 2000 and achieved second leading place for the cause of death. There is a con-tinuous in the development with regard to prevent and different options for treating the cancer. Detection of cancer at its initial stages is very difficult with the help of pathological informatio

APA, Harvard, Vancouver, ISO, and other styles

31

Kamil, Mohammed Y., and Ali Mohammed Salih. "Breast Tumor Detection Via Fuzzy Morphological Operations." International Journal of Advanced Pervasive and Ubiquitous Computing 11, no. 1 (2019): 33–44. http://dx.doi.org/10.4018/ijapuc.2019010103.

Full text

Abstract:

Breast cancer is one of most dangerous diseases and more common in women. The early detection of cancer is one of the most key factors for possible cure. There are numerous methods of diagnosis amongst which: clinical examination, sonar and mammography, which is the best and more effective in detecting breast cancer. Detection of breast tumors is difficult because of the weak illumination in the image and the overlap between regions. Segmentation is one the crucial steps in locating the tumors, which is an important method of diagnosis of the computer. In this study, segmentation techniques ar

APA, Harvard, Vancouver, ISO, and other styles

32

Shantta, Kalifa, and Otman Basir. "Brain Tumor Detection and Segmentation: A Survey." IRA-International Journal of Technology & Engineering (ISSN 2455-4480) 10, no. 4 (2020): 55. http://dx.doi.org/10.21013/jte.v10.n4.p1.

Full text

Abstract:

<p class="Abstract">Even with the enormous progress in medical technology, brain tumor detection is still an extremely tedious and complex task for the physicians. The early and accurate detection of brain tumors enables effective and efficient therapy and thus can result in increased survival rates. Automatic detection and classification of brain tumors have the potential to achieve efficiency and a higher degree of predictable accuracy. However, it is well established that the accuracy performance of automatic detection and classification techniques varies from technique to technique,

APA, Harvard, Vancouver, ISO, and other styles

33

FOK, S. C., E. Y. K. NG, and K. TAI. "EARLY DETECTION AND VISUALIZATION OF BREAST TUMOR WITH THERMOGRAM AND NEURAL NETWORK." Journal of Mechanics in Medicine and Biology 02, no. 02 (2002): 185–95. http://dx.doi.org/10.1142/s0219519402000344.

Full text

Abstract:

Although mammography is still the benchmark technique for breast cancer detection, many advantages of thermography make it a suitable adjunct tool for early detection. This paper describes the development of a computer-aided system for use together with thermography to assist in the detection and visualization/analysis of breast tumors. The system consists of a detection module for predicting the presence of tumors from thermograms, and a visualization module for generating the 3-D volumetric geometry of the suspected tumor inside the breast based on the 2-D thermogram. Detection is achieved t

APA, Harvard, Vancouver, ISO, and other styles

34

Rahayu, Yusnita, and Immanuel Waruwu. "EARLY DETECTION OF BREAST CANCER USING ULTRA WIDE BAND SLOT ANTENNA." SINERGI 23, no. 2 (2019): 115. http://dx.doi.org/10.22441/sinergi.2019.2.004.

Full text

Abstract:

Breast cancer is the transformation of normal cells in the breast area into a malignant tumor, which is the second largest disease as a cause of death for women. Early detection is one way to avoid significant risks in breast cancer. X-ray mammography and magnetic resonance imaging (MRI) techniques are used to detect breast cancer. However, those techniques have several limitations. Ultra-wideband (UWB) microwave imaging, approved by The Federal Communications Commission (FCC) in the United States, has promising capabilities in detecting breast cancer. Microwave imaging uses a microstrip anten

APA, Harvard, Vancouver, ISO, and other styles

35

Najaf-Zadeh, Ayoub. "A Two-Dimensional Convolutional Neural Network for Brain Tumor Detection From MRI." Quarterly of the Horizon of Medical Sciences 26, no. 4 (2020): 398–413. http://dx.doi.org/10.32598/hms.26.4.3303.1.

Full text

Abstract:

Aims: Cancerous brain tumors are among the most dangerous diseases that lower the quality of life of people for many years. Their detection in the early stages paves the way for the proper treatment. The present study aimed to present a two-dimensional Convolutional Neural Network (CNN) for detecting brain tumors under Magnetic Resonance Imaging (MRI) using the deep learning method. Methods & Materials: The proposed method has two stages of feature extraction and classification. A 12-layer CNN was used to extract the features of the MRI images and then the softmax activation function was u

APA, Harvard, Vancouver, ISO, and other styles

36

Hiura, Yui, Toyofumi Nakanishi, Miki Tanioka, Takayuki Takubo та Shinichi Moriwaki. "Identification of Autoantibodies for α and γ–-Enolase in Serum from a Patient with Melanoma". Japanese Clinical Medicine 2 (січень 2011): JCM.S6256. http://dx.doi.org/10.4137/jcm.s6256.

Full text

Abstract:

Melanoma is one of lethal malignant skin tumors and the sole effective cure for the disease can be achieved by surgical resection of primary tumor and early diagnosis for melanoma is crucial for patients' prognosis. Detection of novel tumor-related antibodies would aid in the diagnosis of early-stage cancer, in the detection of recurrence and in the development of a more effective immunotherapy. In the middle of the exploration of a candidate of biomarker for melanoma by proteomics-base technique, we encountered the coexistence of autoantibodies for α-enolase and γ-enolase in serum derived fro

APA, Harvard, Vancouver, ISO, and other styles

37

Corvalan, Alejandro, Maria Jose Maturana, Marianela Sanchez, Alfonso Calvo, and Catterina Ferreccio. "Screening and Triage Test for Early Detection of Gastric Cancer (STEAD-GC): A noninvasive trial for early detection of gastric cancer." Journal of Clinical Oncology 30, no. 30_suppl (2012): 17. http://dx.doi.org/10.1200/jco.2012.30.30_suppl.17.

Full text

Abstract:

17 Background: Gastric cancer (GC) is the second leading cause of cancer-related deaths worldwide. Previously, we identified a potential biomarker for non-invasive detection of GC, the DNA methylation of the promoter region of Reprimo, a p53-dependent G2 arrest mediator candidate (Clin Cancer Res 2008;14:6264-9). Furthermore, we developed a quantitative assay (MethyLight) for a mass screening of GC (DDW2011-1029128). Here we reported the preliminary findings of our ongoing prospective trial STEAD-GC (Screening and Triage test for Early Detection of Gastric Cancer) which is being conducted in C

APA, Harvard, Vancouver, ISO, and other styles

38

Möbius, G. "What can early detection reach at optimal tumor model? Early detection of cervical cancer 1968 to 1985." Journal of Cancer Research and Clinical Oncology 111, S1 (1986): S2. http://dx.doi.org/10.1007/bf02579778.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Abrol, Sachin, Ankush Jairath, Sanika Ganpule, et al. "Can CT Virtual Cystoscopy Replace Conventional Cystoscopy in Early Detection of Bladder Cancer?" Advances in Urology 2015 (2015): 1–6. http://dx.doi.org/10.1155/2015/926590.

Full text

Abstract:

Aim. To correlate findings of conventional cystoscopy with CT virtual cystoscopy (CTVC) in detecting bladder tumors and to evaluate accuracy of virtual cystoscopy in early detection of bladder cancer.Material and Method. From June 2013 to June 2014, 50 patients (46 males, four females) with history and investigations suggestive of urothelial cancer, with mean age 62.76 ± 10.45 years, underwent CTVC by a radiologist as per protocol and subsequently underwent conventional cystoscopy (CPE) the same day or the next day. One urologist and one radiologist, blinded to the findings of conventional cys

APA, Harvard, Vancouver, ISO, and other styles

40

Shen, Zheyu, Aiguo Wu, and Xiaoyuan Chen. "Current detection technologies for circulating tumor cells." Chemical Society Reviews 46, no. 8 (2017): 2038–56. http://dx.doi.org/10.1039/c6cs00803h.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Rohith V, Simmi, and Ramya N. "Kidney tumor detection and classification using image processing." International Journal of Research in Pharmaceutical Sciences 10, no. 3 (2019): 2017–24. http://dx.doi.org/10.26452/ijrps.v10i3.1412.

Full text

Abstract:

Kidney cancer is a disorder where the cells of the kidney become abnormal and develop into a tumor. It is also referred to as renal cell carcinoma. The detection of kidney tumor in the early stages is very important; it is said that different imaging techniques can help doctors to decide the cancer stage and determine the appropriate treatment method. The detection and diagnosis of kidney tumors are performed by scanning images of computed tomography. Most existing works in renal kidney cancer is detection and diagnosis of the existence or absence of tumor in the kidney and classify the tumor

APA, Harvard, Vancouver, ISO, and other styles

42

Lv, Jinzhi, Yanming Miao, and Guiqin Yan. "Detection of tumor marker miRNA21 based on phosphorescent resonance energy transfer of Mn–ZnS QDs." RSC Advances 7, no. 65 (2017): 41063–69. http://dx.doi.org/10.1039/c7ra04521b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Udukala, Dinusha N., Hongwang Wang, Sebastian O. Wendel, et al. "Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection." Beilstein Journal of Nanotechnology 7 (March 7, 2016): 364–73. http://dx.doi.org/10.3762/bjnano.7.33.

Full text

Abstract:

Proteases, including matrix metalloproteinases (MMPs), tissue serine proteases, and cathepsins (CTS) exhibit numerous functions in tumor biology. Solid tumors are characterized by changes in protease expression levels by tumor and surrounding tissue. Therefore, monitoring protease levels in tissue samples and liquid biopsies is a vital strategy for early cancer detection. Water-dispersable Fe/Fe3O4-core/shell based nanoplatforms for protease detection are capable of detecting protease activity down to sub-femtomolar limits of detection. They feature one dye (tetrakis(carboxyphenyl)porphyrin (T

APA, Harvard, Vancouver, ISO, and other styles

44

Fiala, Clare, and Eleftherios P. Diamandis. "Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detection." Clinical Chemistry and Laboratory Medicine (CCLM) 58, no. 10 (2020): 1651–53. http://dx.doi.org/10.1515/cclm-2020-0083.

Full text

Abstract:

AbstractThe important conclusion that ctDNA is a mediocre proxy for liquid biopsies of tumor tissues for early detection was reached after new data were published recently in Nature Genetics. These data have shown that most mutations found in ctDNA are not related to tumor tissues but rather to the precancerous condition clonal hematopoiesis. Previously, our group has analyzed the sensitivity of the ctDNA test for early detection of cancer and concluded that the achievable sensitivity, especially for small tumors, is not enough to have clinical value. Now, the new data have shown a serious com

APA, Harvard, Vancouver, ISO, and other styles

45

Hartwig, Anna, Carlo Artieri, Ariel Jaimovich, et al. "Analytical validation of a tumor-agnostic integrated multianalyte circulating tumor DNA (ctDNA) assay in early-stage cancer." Journal of Clinical Oncology 37, no. 15_suppl (2019): 3057. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3057.

Full text

Abstract:

3057 Background: ctDNA sequencing has been rapidly adopted for the identification of targetable somatic alterations (alts) in patients with advanced cancers. However, early stage disease detection has been hindered by low levels of ctDNA in circulation and the presence of confounding non-tumor-related somatic alts. We developed and validated a ctDNA assay that combines somatic and epigenomic signals to detect early stage tumors without tumor tissue or white blood cells (WBC). Methods: Using a single input sample, our assay integrates the sensitive detection of genomic alts with quantification

APA, Harvard, Vancouver, ISO, and other styles

46

Zhou, Han, Xin Du, and Zhenguo Zhang. "Electrochemical Sensors for Detection of Markers on Tumor Cells." International Journal of Molecular Sciences 22, no. 15 (2021): 8184. http://dx.doi.org/10.3390/ijms22158184.

Full text

Abstract:

In recent years, the increasing incidence and mortality of cancer have inspired the development of accurate and rapid early diagnosis methods in order to successfully cure cancer; however, conventional methods used for detecting tumor cells, including histopathological and immunological methods, often involve complex operation processes, high analytical costs, and high false positive rates, in addition to requiring experienced personnel. With the rapid emergence of sensing techniques, electrochemical cytosensors have attracted wide attention in the field of tumor cell detection because of thei

APA, Harvard, Vancouver, ISO, and other styles

47

Siddiqui, Ayesha Aamir, Ghous Baksh Narejo, Areeba Mehmood Khan, and Mashal Tariq. "Early Skin Tumor Detection from Microscopic Images through Image Processing." Mehran University Research Journal of Engineering and Technology 36, no. 4 (2017): 915–20. http://dx.doi.org/10.22581/muet1982.1704.16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Blasiak, Barbara, Boguslaw Tomanek, Abedelnasser Abulrob, et al. "Detection of T2 changes in an early mouse brain tumor." Magnetic Resonance Imaging 28, no. 6 (2010): 784–89. http://dx.doi.org/10.1016/j.mri.2010.03.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Mwesige, Benjamin, Seung-Gu Yeo, and Byong Chul Yoo. "Circulating Tumor Cells: Liquid Biopsy for Early Detection of Cancer." Soonchunhyang Medical Science 25, no. 1 (2019): 1–9. http://dx.doi.org/10.15746/sms.19.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Tariq, Mashal, Attaullah Khawajah, and Munawer Hussain. "Image Processing with the Specific Focus on Early Tumor Detection." International Journal of Machine Learning and Computing 3, no. 5 (2013): 404–7. http://dx.doi.org/10.7763/ijmlc.2013.v3.349.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!